Prosecution Insights
Last updated: October 25, 2026

British Columbia Cancer Agency Branch

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

British Columbia Cancer Agency Branch has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed between 2 distinct examiners and 2 distinct art units. This distribution shows that each pending matter is being reviewed by a different examiner in a different specialized unit. The involvement of 2 distinct examiners suggests that the agency must navigate different examination styles even with a small number of active cases.

The busiest examiner for the agency is HARVEY, JULIANNA NANCY, who manages 1 busiest examiner pending action. Since there are 2 pending office actions in total and 2 distinct examiners, each examiner is responsible for 1 action. With 2 distinct art units involved, the prosecution strategy must be adaptable to different internal policies and technical standards. This decentralized arrangement for only 2 actions indicates that the agency's medical technology spans multiple classifications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
0
Medium (0%)
1
Easy (50%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
50% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HARVEY, JULIANNA NANCY 1 77.7% +19.1%
SHIAO, REI TSANG 1 79.9% -33.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18945941 SHAPE ADAPTABLE INTRAMEDULLARY FIXATION DEVICE HARVEY, JULIANNA NANCY —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18945941 SHAPE ADAPTABLE INTRAMEDULLARY FIXATION DEVICE HARVEY, JULIANNA NANCY —

Top Art Units

Art UnitApps
3773 1
1691 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18945941 SHAPE ADAPTABLE INTRAMEDULLARY FIXATION DEVICE HARVEY, JULIANNA NANCY 3773 §102§103 Non-Final OA — Pending Nov 13, 2024
18791751 HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE SHIAO, REI TSANG 1691 DP Non-Final OA — Pending Aug 01, 2024

Managing British Columbia Cancer Agency Branch's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does British Columbia Cancer Agency Branch have?

British Columbia Cancer Agency Branch has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most British Columbia Cancer Agency Branch applications?

Julianna Nancy Harvey has the most, with 1 of British Columbia Cancer Agency Branch's pending office actions.

What technology area are British Columbia Cancer Agency Branch's patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month